AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Test can rule out bladder cancer in hematuria.(Clinical Rounds)

OB GYN News

| July 01, 2006 | MacNeil, Jane Salodof | COPYRIGHT 2006 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

PARIS -- The noninvasive NMP22 BladderChek assay gives primary care physicians a way to screen asymptomatic patients with hematuria for bladder cancer during office visits, Dr. H. Barton Grossman said at the annual congress of the European Association of Urology.

"At least in the United States, most of these patients are not being tested at all, not being referred to urologists, until they have several episodes of significant blood in their urine," said Dr. Grossman, professor and chairman of urology at the M.D. Anderson Cancer Center in Houston.

The test, approved for use in the United States and Europe, uses four drops of urine and gives results in 30 minutes at a cost of $25-$50 per patient, according to Dr. Grossman. A positive finding is based on an NMP22 antigen level of 10 U/mL or greater. Malignant cancer cells have been found with concentrations up to 80 times greater than those found in normal cells, he said.

"I think the best use of this test is actually going to be in the initial diagnosis of people with hematuria in general practice offices," he told European urologists who questioned whether the NMP22 protein assay yields too many false-positive results for urologists to find it clinically useful.

Dr. Grossman presented updated results from a large study that found that the NMP22 protein assay can increase the accuracy of screening when used in combination with cystoscopy (JAMA 2005;293:810-6). The investigators compared the NMP22 test results with cytology results, with cystoscopy as the reference standard. Patients provided a voided urine sample before undergoing cystoscopy. The urine sample was divided into two parts: One portion was tested for NMP22 in the office, and the other was sent for routine cytology. If a tumor was found and removed during cystoscopy, diagnosis was based on pathology of the tumor.

A total of 23 academic, private practice, and veterans' facilities in 10 states recruited high-risk patients from September 2001 to February 2002. Of ...

Related articles from newspapers, magazines, journals, and more
What do I tell my patients about drinking water and the risk of bladder...
Magazine article from: Urologic Nursing Moyad, Mark A. October 1, 2003 700+ words
...1999). In the United States, over 56,000 new cases of bladder cancer are expected...skin cancer, bladder cancer in the United States is the fourth...than 50% of the bladder cancer cases in the United States, with smoking...
FDA Approves First Gene-Based Test, UroVysion(TM), for Diagnosis of Patients...
Press release article from: PR Newswire January 25, 2005 700+ words
...new cases of bladder cancer diagnosed in the United States (about 47...deaths from bladder cancer in the United States (about 9...a third of bladder cancer deaths in women...people in the United States have a history...
Lived female experience of chronic bladder cancer: a phenomenologic case...
Magazine article from: Urologic Nursing Hilton, Edith L. Henderson, Lesley J. October 1, 2003 700+ words
...400 new cases of bladder cancer in the United States in 2003 and that 15...900 total deaths from bladder cancer with 3,900 (31%) deaths in females with bladder cancer during 2003 in the United States (ACS, 2003). Invasive...
Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial...
Press release article from: PR Newswire September 7, 2007 700+ words
...people suffering from bladder cancer in the United States and more than 935 thousand...160 new cases of bladder cancer will be found in the United States. According to Globocan...will be diagnosed with bladder cancer in Europe during 2007...
Matritech signs Japanese distribution agreement with Konica for NMP-based...
Press release article from: Business Wire November 21, 1994 700+ words
...its NMP22 urine assay for bladder cancer involving hundreds of patients...Matritech NMP22 Test Kit for bladder cancer to the United States Food and Drug Administration...Matritech NMP22 Test Kit for bladder cancer, certainly are important...
University of Iowa Physician Working on Bladder Cancer Awareness, Treatments.
News wire article from: Ascribe Higher Education News Service June 25, 2002 700+ words
...candidates for the combined bladder cancer treatment. He developed...investigating ways to improve bladder cancer treatment, O'Donnell is...College of Medicine, to study bladder cancer rates in the United States. The team is analyzing various...
New staging technique might save bladders in some bladder cancer patients.
Newspaper article from: NewsRx Health March 29, 2009 700+ words
...In a study of 70 bladder cancer specimens, the...meeting of the United States and Canadian Academy...000 new cases of bladder cancer in the United States last year, and...five stages of bladder cancer, ranging from...
Data on bladder cancer reported by researchers at University of Colorado.
Newspaper article from: Cancer Weekly July 21, 2009 700+ words
...treatment of patients with bladder cancer," scientists in the United States report (see also Bladder Cancer). "Activation of mitogen...116 35, Greece. Keywords: United States, Denver, Bladder Cancer, Bladder Carcinoma, Enzyme...
For more facts and information, see all results

Source: HighBeam Research, Test can rule out bladder cancer in hematuria.(Clinical Rounds)

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA